Completed PHASE2 INTERVENTIONAL 1-arm NCT00002860

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

A Phase II Trial of Complete Surgical Resection For Stage IV Melanoma -- Surgical Resection With Biological Evaluation and Clinical Follow-Up

Sponsor: Eastern Cooperative Oncology Group

Conditions Melanoma (Skin)

Interventions Surgery

Updated 7 times since 2017 Last updated: Jan 11, 2012 Started: Nov 30, 1996 Primary completion: Dec 31, 2006 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Melanoma (Skin), this trial is completed. The trial is conducted by Eastern Cooperative Oncology Group and has accumulated 7 data snapshots since 1996. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
May 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — May 2023 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
SWOG Cancer Research Network

Data source: SWOG Cancer Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alton, United States , Amarillo, United States , American Fork, United States , Anchorage, United States , Ann Arbor, United States , Battle Creek, United States , Bellingham, United States , Bethlehem, United States , Big Rapids, United States , Billings, United States and 72 more locations